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THE EFFECT OF PHOSPHATE AVAILABILITY ON CHONDROCYTE METABOLIC FUNCTION 
KEVIN C. BLANK 
ABSTRACT 
 Dietary phosphate is essential for normal fracture healing and bone growth. 
Previous studies have established that mice given a phosphate deficient diet after a 
fracture demonstrate delayed cartilage maturation and callus mineralization, as well as 
changes in gene expression consistent with oxidative phosphorylation dysfunction.  This 
study was undertaken in order to examine the role of inorganic and organic phosphate 
availability on chondrocyte differentiation and mineralization, and to define the 
relationship between these processes and changes in chondrocyte metabolic function. 
 ATDC5 murine chondroprogenitor cell line, which has been shown to undergo in 
vitro differentiation and  extracellular matrix mineralization, was cultured under both 
differentiating and non-differentiating media conditions under conditions in 1mM -
0.25mM sodium phosphate monobasic (inorganic phosphate) in the presence or 
absence of 4mM β-glycerol phosphate (organic phosphate).  In the first series of studies, 
overall cell growth (total DNA and protein contents), mineralization (calcium 
accumulation), and cell-normalized oxidative metabolism (basal respiration, maximal 
respiration, ATP turnover, spare capacity, proton leak, and non-mitochondrial 
respiration rates) were measured over a 28 day time course in cultures grown in  
differentiating  (ascorbic acid, insulin-transferrin-selenium, and β-glycerol phosphate) 
conditions in 1mM phosphate.   
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These studies found that when the cells were induced to differentiate, there was 
a measurable increase in protein content while DNA content decreased by 30%, 
indicating a fraction of the cells underwent cell death. Differentiation was further 
associated with an overall two-fold increase in oxidative respiration. Next we assessed 
how differentiation, the promotion of matrix mineralization, and inorganic phosphate 
availability affected oxidative respiration.  When differentiation was not induced with 
ascorbic acid and β-glycerol phosphate, there was no over growth in the cultures nor 
any change in total extracellular matrix mineralization or oxidative respiration.  In the 
absence only of β-glycerol phosphate, differentiation proceeded but matrix 
mineralization did not occur. However, overall protein content and oxidative respiration 
were statistically two- and 1.5-fold higher, respectively, independent of the inorganic 
phosphate contents of the growth media. These results suggest that both differentiation 
and overall protein accumulation are strongly associated with increased oxidative 
metabolism while mineralization of the matrix decreased oxidative function.  Only at the 
lowest phosphate levels were changes in basal oxidative function observed.  These 
results are consistent with previous in vivo findings suggesting that diminished 
expression of mitochondrial associated genes in callus tissues from hypophosphatemic 
mice were associated with an overall decrease in chondrocyte differentiation.    
  viii 
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INTRODUCTION 
 
Bone Development 
 The vertebrate skeleton is derived from mesenchymal stem cells, which 
condense at the site of future bone formation before becoming committed to an 
osteochondrogenic cell lineage and laying the foundation for bone mineralization 
(Kozhemyanika, et al. 2015; Melrose, et al. 2016; Olsen, et al. 2000). There are two 
distinct processes by which mesenchymal stem cells differentiate and produce bone: 
intramembranous ossification and endochondral ossification. During intramembranous 
ossification, mesenchymal condensations are invaded by the vasculature, causing the 
stem cells to differentiate into osteoblasts. These mature osteoblasts secrete an 
extracellular matrix of unmineralized osteoid which is subsequently mineralized and 
remodeled (Karsenty, 2003). 
 With the notable exception of the flat bones of the cranium and parts of the 
mandible and clavicle – which develop through intramembranous ossification – the 
majority of the skeleton is formed through endochondral ossification (Melrose, et al. 
2016). Endochondral ossification (Figure 1) is a stepwise process in which a cartilaginous 
matrix secreted by embedded chondrocytes serves as a template for subsequent 
mineralization (Kozhemyakina, et al. 2015; Melrose, et al. 2016). Endochondral 
ossification also plays an important postnatal role in fracture healing; after a fracture, 
mesenchymal stem cells are recruited to the fracture site and undergo chondrogenic 
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differentiation to produce a cartilaginous callus that is then mineralized (Gerstenfeld, et 
al. 2003). 
During fetal development, endochondral ossification begins with the recruitment 
of undifferentiated mesenchymal stem cells to condensations that will eventually 
become limb buds (Melrose, et al. 2016; Olsen, et al. 2000.) Initial chondrocyte 
differentiation is marked by the expression of the gene Sox9, a key regulator of 
chondrogenic differentiation (Henry, et al. 2012).  These newly-differentiated 
chondrocytes express Col2a1 and Aggrecan, and begin to synthesize an extracellular 
matrix consisting largely of type II collagen and aggrecan proteoglycan (Henry, et al. 
2012; Kozhemyakina, et al. 2015; Olsen, et al. 2000). This stage of chondrocyte 
differentiation is also marked by rapid proliferation (Mebarek, et al. 2013). The 
transition to the next stage is marked by a drastic decrease in Sox9 expression, 
decreased type II collagen synthesis,  and increased expression of ColXa1, an indicator of 
type X collagen synthesis (Henry, et al. 2012; Mebarek, et al. 2013; Kozhemyakina, et al. 
2015). These chondrocytes enter a hypertrophic stage, withdrawing from the cell cycle 
and increasing dramatically in size. Hypertrophic chondrocytes are the major drivers of 
matrix mineralization; they remodel the surrounding extracellular matrix, replacing type 
II collagen with type X collagen, and begin the process mineral crystal deposition 
(Magne, et al. 2003; Mebarek, et al. 2013). The ultimate fate of terminally differentiated 
hypertrophic chondrocytes remains a matter of debate.  While it has been established 
that hypertrophic chondrocytes undergo apoptosis as the growth plate mineralizes, 
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some studies suggest that a subset of hypertrophic chondrocytes may undergo further 
differentiation into the osteoblastic cell line (reviewed in Tsang, et al. 2014). Several 
osteogenic genes, in particular Runt-related transcription factor 2 (RUNX2) and Osterix 
(Osx), are expressed by cells derived from both chondrocyte and osteoblast precursors. 
Additionally, some morphological studies have observed hypertrophic chondrocytes 
undergoing asymmetrical mitosis to produce an osteoblast-like daughter cell. Regardless 
of whether their fate is death or further differentiation, hypertrophic chondrocytes 
within the mineralizing matrix are ultimately replaced by osteoblasts, which 
subsequently remodel the calcified cartilage to produce mature bone (Melrose, et al. 
2016; Tsang, et al. 2014).  
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Figure 1. Representation of chondrocyte differentiation in the growth plate during 
endochondral ossification. (A) Mesenchymal stem cells condense. (B) Condensed mesenchymal 
cells differentiate; cells at the periphery become the perichondrium, while cells at the interior 
will establish the template for bone mineralization. (C) Differentiated chondrocytes form 
proliferative and hypertrophic bones, laying down an unmineralized extracellular matrix 
consisting of collagen and proteoglycans. (D) The extracellular matrix is mineralized, 
hypertrophic chondrocytes undergo apoptosis, and blood vessels invade the newly formed 
bone. (From Melrose, et al. 2016) 
 
The Role of Phosphate in Bone Development 
I. Chondrocyte Differentiation 
Dietary phosphate is essential for proper bone development, mineralization, and 
fracture healing (Penido and Alon, 2012; Sugita, et al. 2011). Insufficient dietary 
phosphate – or the inability to absorb phosphate from the diet – results in a condition 
known as hypophosphatemic rickets (Elder, et al. 2014; Feng, et al. 2013; Penido and 
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Alon, 2012; Sugita, et al. 2011). The result is an abnormal growth phenotype in which 
bone elongation, mineralization, and vascular infiltration are delayed, and apoptosis of 
hypertrophic chondrocytes is inhibited (Feng, et al. 2013; Sugita, et al. 2011). During 
endochondral ossification, a phosphate gradient develops in the growth plate, 
increasing from the proliferative zone to the hypertrophic zone (Denison, et al. 2009; 
Kimata, et al. 2009; Penido and Alon, 2012). The increased phosphate concentration at 
the hypertrophic zone has been shown to have a number of important effects on the 
later stages of chondrocyte differentiation and the mineralization of the extracellular 
matrix. Increased phosphate in the hypertrophic zone of the growth plate has been 
shown to induce apoptosis in hypertrophic chondrocytes, a process necessary for matrix 
mineralization and vascular infiltration (Denison, et al. 2009; Magne, et al. 2003; 
Mebarek, et al 2013). In the absence of adequate phosphate, apoptosis of terminally-
differentiated hypertrophic chondrocytes is inhibited, resulting in the pathological 
elongation of the growth plate and a failure to mineralize the extracellular matrix 
(Penido and Alon, 2012; Sugita, et al. 2011). 
 
II. Matrix Mineralization 
Phosphate is required for the synthesis of hydroxyapatite (Ca10(PO4)6(OH)2), the 
main mineral component of bone. Under physiological conditions, much of the 
phosphate available to chondrocytes is organic phosphate in the form of β-glycerol 
phosphate (Penido and Alon, 2012). β-glycerol phosphate (βGP) is cleaved by the plasma 
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membrane-embedded enzyme alkaline phosphatase to produce free inorganic 
phosphate. The phosphate ion is then uptaken by the hypertrophic chondrocyte via a 
sodium-dependent phosphate transporter (Denison, et al. 2009; Penido and Alon, 
2012). Once inside the cell, phosphate is incorporated into matrix vesicles, membrane-
bound organelles in which calcium and phosphate are combined to form hydroxyapatite 
(Mebarek, et al 2013; Shapiro, et al. 2015). The hypertrophic chondrocyte then 
undergoes apoptosis, releasing these mineral-containing matrix vesicles are into the 
extracellular matrix where they first remodel the matrix using metalloproteinases 
(Gerstenfeld, et al. 2003). Once the extracellular matrix has been prepared by the 
metalloproteinases, the hydroxyapatite contained in the matrix vesicles crystallizes 
within the extracellular matrix to form the main mineral component of the bone 
(Karsenty, 2003; Melrose, et al. 2016; Mebarek, et al. 2013; Shapiro, et al. 2015). Finally, 
the newly mineralized bone is invaded by blood vessels originating in the perichondrium 
(Karsenty, 2003; Melrose, et al. 2016). While it is well established that phosphate is 
essential for these processes, it is unclear whether the nature of the phosphate source 
affects the ability of chondroprogenitors to differentiate and mineralize. Previous 
studies have shown that mineralization can be induced in chondrocyte cell lines by 
supplementation with 10 mM inorganic phosphate (Fujita, et al. 2000). Recently, it has 
been shown that ATDC5 murine chondroprogenitor cells grown in differentiating media 
supplemented with β-glycerol phosphate express genes associated with chondrocyte 
differentiation and develop hydroxyapatite mineral deposits, while those not 
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supplemented with β-glycerol phosphate do not mineralize (Cooke and Gerstenfeld, 
2015). These findings provide a useful model with which to study changes in 
chondrocyte function specific to terminal differentiation and mineralization. 
 
Chondrocyte Metabolism 
 While the processes of extracellular matrix development and mineralization have 
been studied extensively, relatively little research has been directed at understanding 
how chondrocytes generate and use energy during these processes. Since chondrocytes 
are embedded in the extracellular matrix – a largely avascular region – they have little 
access to oxygen (Shapiro and Srinivas, 2006). As a result, chondrocytes in the growth 
plate generate most of their energy through glycolysis, almost entirely depleting their 
surrounding microenvironment of glucose (Shapiro and Srinivas, 2006; Heywood, et al. 
2005). In this oxygen-poor microenvironment, the highly efficient but oxygen-
dependent process of oxidative phosphorylation (Figure 2) is suppressed by the 
activation of hypoxia-inducible factor 1 (HIF-1) (Kim, et al. 2006). At the same time, HIF-
1 promotes the use of glycolytic metabolites in anaerobic respiration, allowing the cell 
to maintain ATP production in the absence of oxygen (Kim, et al. 2006; Shapiro and 
Srinivas, 2006).  
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Figure 2. Canonical oxidative phosphorylation pathway. The mitochondrion establishes a 
proton (H+) gradient along the inner mitochondrial membrane through progressive steps of 
oxidation in the electron transport chain (Complex I-III). The electrochemical potential energy 
generated by the proton gradient is then used to power ATP synthase (Complex V), which 
phosphorylates adenosine monophosphate (AMP) and adenosine diphosphate (ADP) to produce 
adenosine triphosphate (ATP). Oligomycin inhibits the F0 domain of ATP synthase, preventing 
the phosphorylation of AMP and ADP. FCCP disrupts the inner mitochondrial membrane, 
decoupling the proton gradient from ATP synthase. Antimycin A inhibits the electron transport 
chain at Complex III, preventing the formation of the proton gradient. (From Lippincott’s 
Biochemistry, 5th Edition) 
 
The role of oxidative phosphorylation in chondrocyte function is not yet well 
understood. Studies of articular chondrocytes have shown that chondrocytes produce as 
little as 5% of their ATP from oxidative phosphorylation (Heywood and Lee, 2009). 
Articular chondrocytes grown in a monolayer culture in the presence of 20% oxygen 
increase their rate of oxidative phosphorylation dramatically, producing as much as 36% 
of their ATP through oxidative phosphorylation and increasing their mitochondrial mass 
significantly (Heywood and Lee, 2016). While these studies shed some light on how 
mature chondrocytes respond to increased oxygen availability, they do not address the 
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metabolic changes that occur during differentiation and mineralization. A study by 
Johnson, et al. (2000) suggested that inhibition of oxidative phosphorylation with 
oligomycin, an inhibitor of ATP synthase, and antimycin A, an inhibitor of complex II of 
the electron transport chain (see Figure 2) interfered with chondrocytic collagen and 
proteoglycan synthesis. While this study suggested that oxidative phosphorylation 
dysfunction contributes to cartilage loss, it was not able to assess which aspects of 
oxidative phosphorylation were responsible for the reduced extracellular matrix 
synthesis. Additionally, it has been shown that hydroxyapatite mineral formation can be 
induced in mature chondrocytes treated with exogenous ATP (Hatri, et al. 1995). 
Metabolic changes associated with osteogenic differentiation have also been studied in 
primary murine osteoblasts (Komarova, et al. 2000). In this study, differentiation was 
found to induce a four-fold increase in oxidative respiration, and a switch from glycolysis 
to oxidative phosphorylation as the primary source of ATP production. 
Recently, the tools available to assess changes in oxidative phosphorylation have 
advanced significantly, allowing researchers to manipulate oxidative phosphorylation in 
real time. The Seahorse Extracellular Flux Mitochondrial Stress Test (Seahorse XF test) 
allows researchers to measure changes in oxidative phosphorylation and glycolysis in 
real time (Figure 3). During the XF test, known amounts of oxygen are mixed into a 
closed system with the cells and the change in oxygen concentration and pH are 
measured periodically. In order to assess different parameters of oxidative 
phosphorylation, inhibitors of specific steps in the oxidative phosphorylation are 
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injected into the assay medium between measurements. The changes in oxygen 
consumption rate (OCR) caused by these inhibitors can are then used to calculate 
various parameters of oxidative phosphorylation, including basal OCR, maximal OCR, 
and oxygen consumed in the process of ATP synthesis. 
 
Figure 3. Representative diagram of oxygen consumption rate measurements. Oxygen 
consumption rate (OCR) was assessed using the Seahorse XF24 Extracellular Flux Mitochondrial 
Stress Test. After the basal respiration rate is established, oligomycin is injected, inhibiting the F0 
subunit of ATP synthase. The difference between the basal and post-oligomycin OCR is 
attributed to the loss of ATP production in the cells. Following these measurements, FCCP is 
injected, uncoupling the proton gradient and allowing the assessment of maximal respiratory 
capacity. Finally, Antimycin A is injected, inhibiting complex III of the electron transport chain 
and effectively ceasing all oxidative phosphorylation. Any oxygen consumption after antimycin A 
injection can be attributed to non-mitochondrial respiration. (Adapted from Seahorse 
Bioscience XF Stress Test Report Generator User Guide). 
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Several recent studies have utilized the Seahorse XF test to better understand 
the changes in energy metabolism that take place during osteoblastic and chondrocytic 
differentiation. Guntur, et al. (2014) investigated the metabolic changes induced by 
differentiation in a preosteoblastic cell line (MC3T3-E1C4) and in primary calvarial 
osteoblasts harvested from C3H and B6 mouse strains. Across all three cell types, 
differentiation was associated with increased rates of oxidative and glycolytic 
metabolism compared to undifferentiated cells. Interestingly, this study found that 
osteoblasts harvested from C3H mice had a higher rate of oxygen consumption than 
those harvested from B6 mice. In vivo, C3H mice produced more bone than B6 mice, 
suggesting that the elevated oxygen consumption in C3H osteoblasts might be linked to 
this difference in bone formation. 
Shum, et al. (2016) examined the metabolic, morphologic, and genetic changes 
in a mesenchymal stem cell line undergoing osteoblastic differentiation. A human 
mesenchymal stem cell (MSC) line was cultured in osteogenic differentiating medium 
and was compared to undifferentiated mesenchymal stem cells at day 21. The 
differentiated osteoblasts demonstrated significantly increased rates oxygen 
consumption compared to the undifferentiated MSCs, indicating that differentiation 
resulted in an increased rate of oxidative phosphorylation. The increased rate of 
oxidative phosphorylation could not be attributed to an increase in mitochondrial 
biogenesis, suggesting that the increase was due to a change in metabolic regulation in 
the differentiated cells. RNA sequencing revealed marked suppression of the oxidative 
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phosphorylation inhibitor HIF-1in the differentiated cells, which further suggested that 
osteoblastic differentiation was associated with a switch from glycolysis to oxidative 
phosphorylation as the primary source of energy. 
While these studies are largely consistent in their findings – namely, that MSC 
differentiation is associated with an increase in the rate of oxidative metabolism – 
neither study investigated the metabolic changes specific to the mineralization step of 
differentiation, nor did they examine the effects of specific nutrients on metabolic 
function in these cells. Additionally, since both of these studies limited their 
investigation to osteoblastic cell lineages, their results cannot be directly applied to our 
understanding of the chondrocyte-centered process of endochondral ossification. 
 
Motivation 
 A recent study has shown that three inbred strains of mice (AJ, C3H, and B6) 
given a phosphate restricted diet exhibit delayed fracture healing (Lybrand, et al. 2014). 
Microarray analysis of the fracture calluses of these mice revealed changes in gene 
expression consistent with oxidative phosphorylation dysfunction (Hussein, et al. 2015). 
Many of the genes associated with the canonical oxidative phosphorylation pathway 
were downregulated in phosphate restricted mice (Figure 4). While dietary phosphate 
restriction is known to inhibit bone development and fracture healing, the mechanisms 
of these effects are not well understood. The finding that oxidative phosphorylation 
pathways were among those most significantly affected by the phosphate restriction 
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suggests that these metabolic pathways are essential for normal chondrocyte 
differentiation and fracture healing. 
  
Figure 4. Top canonical pathways affected by dietary phosphate restriction in mouse fracture 
calluses. Closed stabilized femoral fractures were induced in mice that were then given either a 
normal or phosphate-deficient diet. Fracture calluses were harvested between 3 and 35 days 
post-fracture. Total RNA was isolated from the calluses and gene expression was analyzed using 
microarray. Mice given a phosphate deficient diet demonstrate changes in gene expression 
consistent with dysfunction of the oxidative phosphorylation pathway. (From Hussein, et al. 
2015) 
 
Study Goals 
This study was undertaken in order to better understand roles of inorganic and 
organic phosphate availability in chondrocyte differentiation, mineralization, and 
metabolic function. Using an ATDC5 chondroprogenitor cell model, this study attempts 
to identify the changes in oxidative phosphorylation that take place during chondrocyte 
differentiation and mineralization, and to elucidate the role that oxidative metabolism 
plays during these processes. 
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The specific aims were:  
1. To measure oxygen consumption rate under different conditions of phosphate 
availability. 
2. To assess the effect of phosphate availability on mineral and protein 
accumulation in differentiated chondrocytes. 
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METHODS 
 
Experimental Design 
I. Pilot Study 
A pilot study was undertaken in order to determine whether the Seahorse XF 24 
Mitochondrial Stress Test was an appropriate method of studying the ATDC5 cell line 
oxygen consumption and to identify key timepoints to measure OCR. ATDC5 
chondroprogenitors were expanded in growth medium (see Table 1) and plated on 
Seahorse XF24 cell culture plates (Seahorse Bioscience Inc., North Billerica, MA) at a 
density of 1.5x103 cells/well and allowed to reach confluence. The culture medium was 
then changed to a Full Pi differentiating medium containing ascorbic acid (Sigma-Aldrich, 
St. Louis, MO), 1X insulin-transferrin-selenium (Lonza Walkersville Inc, Walkersville, MD) 
and 4 mM β-glycerol phosphate (Sigma-Aldrich, St. Louis, MO) (see Table 1). At days 7, 
14, 21, and 28 post-confluence, oxygen consumption rate (OCR) was assessed using a 
Seahorse XF24 Mitochondrial Stress Test and total DNA content was quantified using a 
PicoGreen (Life Technologies Inc, Beverly, MA) fluorescence assay (Figure 3). All OCR 
measurements were normalized to well DNA content and calculated according to the 
Seahorse Bioscience XF Stress Test User Guide (Table 2). 
 
II. Primary Experiments 
 Based on the results of the pilot study, days 7 and 21 were chosen as the focus 
of the subsequent experiments. In order to assess mineral accumulation, protein 
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accumulation, gene expression, and oxygen consumption in differentiating 
chondrocytes under various conditions of phosphate availability, two main experiments 
were undertaken: 
A. Mineral Accumulation: At days 0, 7, 14, 21, and 28 post-confluence, and 
mineral accumulation was quantified using alizarin red staining. Mineral 
accumulation and was assessed in cells cultured in Half Pi and Full Pi 
media conditions ± 4mM βGP, and was normalized to cell number as 
approximated by MTT assay.  
B. Oxygen Consumption and Protein Accumulation: At days 7 and 21 post-
confluence, OCR was assessed using the Seahorse XF24 Mitochondrial 
Stress Test and protein accumulation was quantified using the MicroBCA 
protein assay. OCR and protein accumulation were normalized to well 
DNA content quantified by Picogreen assay. OCR and protein 
accumulation were assessed in cells cultured in Quarter Pi, Half Pi, and 
Full Pi media conditions ± 4mM βGP. Cells cultured in growth medium 
served as a negative control. 
 
Cell Model 
  ATDC5 murine chondroprogenitor cells were expanded in growth medium 
consisting of DMEM/F12 1:1 mixture (Life Technologies Inc, Beverly, MA) with 5% fetal 
bovine serum (Life Technologies Inc, Beverly, MA) and 1% penicillin/streptomycin 
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antibiotic (Mediatech Inc, Herndon, VA) in a humidified incubator (37∘C, 5% CO2). For 
the oxygen consumption rate and protein accumulation experiments, the cells were 
seeded on XF24 cell culture plates (Seahorse Bioscience Inc., North Billerica, MA) at a 
density of 1.5x103 cells per well. For the mineralization and MTT experiments, cells were 
seeded on 12 well cell culture plates (Corning Inc, Corning, NY) at a density of 1.73x105 
cells per well. For the RNA extraction, cells were seeded on 6 well cell culture plates 
(Corning Inc, Corning, NY)  at a density of 4.32x105 cells per well. For all experiments, 
once the cells had been seeded, they were incubated for 2-3 days in growth medium to 
allow them to reach confluence. When confluence was achieved, the culture medium 
was changed to one of three differentiating media types: full phosphate, half 
phosphate, or quarter phosphate (see Table 1). Differentiation was induced by 
supplementation with 1X insulin-transferrin-selenium (Lonza Walkersville Inc, 
Walkersville, MD) and 0.2 mM ascorbic acid (Sigma-Aldrich, St. Louis, MO). Half of the 
wells received 4 mM β-glycerol phosphate (Sigma-Aldrich, St. Louis, MO), while the 
other half received no β-glycerol phosphate. For the oxygen consumption rate and 
protein accumulation experiment, one group remained in growth medium for the 
entirety of the experiment in order to serve as a negative control. 
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Table 1. Media conditions. All media conditions were supplemented with 5% fetal bovine 
serum (Life Technologies) and 1% penicillin/streptomycin (Mediatech). Ascorbic acid was 
added to the differentiating media conditions immediately before media changes. 1Life 
Technologies, 2Lonza BioWhittaker, 3Sigma-Aldrich. 
 Medium 
 Growth/Control Full Pi   Half Pi Quarter Pi 
Base                           αMEM
1    αMEM without sodium bicarbonate and 
sodium monophosphate
1 
Differentiating 
Supplements 
N/A        1X insulin-transferrin-selenium
2
, 0.2 mM ascorbic acid
3 
Mineral 
Supplements 
N/A N/A 
2.5 mM sodium 
bicarbonate
3
  
0.5 mM sodium 
monophosphate
3 
2.5 mM sodium 
bicarbonate
3 
 0.25 mM sodium 
monophosphate
3 
Final [Pi] (mM) 1.0 1.0 0.5 0.25 
 
Mineral Quantification 
 At each timepoint (7,14, 21 and 28 days post-confluence), cells were washed 
with 1X phosphate buffered saline without calcium or magnesium (Mediatech Inc, 
Herndon, VA) and were fixed with 2% paraformaldehyde. After fixation was complete, 
the paraformaldehyde was aspirated and the cells were washed with distilled water. 
Wells were stained with 450µL of Alizarin red 1X solution (EMD Millipore, Billerica, MA) 
and incubated at 37∘C for 30 minutes. The stain was then aspirated and the cells were 
washed with distilled water. 200µL of 10% acetic acid were added to each well and the 
culture plate was placed on a shaker for 30 minutes. The cells were then scraped into 
1.5mL microcentrifuge tubes, vortexed, and heated to 85∘C for 10 minutes. The tubes 
were cooled on ice for a minimum of 5 minutes before being centrifuged at 20,000rpm 
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for 20 minutes. 175µL of the supernatant fluid was transferred to microcentrifuge tubes 
containing 66µL of 1M NH3OH. 100µL of each sample was aliquoted into a 96 well 
microplate (Thermo Fisher Scientific, Waltham, MA) in duplicate and the absorbance 
was read at 405nm using a BioTek Synergy 2 Multi-mode Microplate Reader (BioTek 
Instruments Inc, Winooski, VT). Well mineral content was normalized to cell number as 
approximated by MTT assay. 
 
MTT Assay 
 At each timepoint (days 0, 7, 14, 21, and 28 post-confluence), a thiazolyl blue 
tetrazolium bromide (MTT) assay was performed in order to approximate cell number 
and normalize the mineral accumulation under Full Pi ± βGP and Half Pi ± βGP 
conditions. Cells were washed with 1X phosphate buffered saline without calcium or 
magnesium and 700µL αMEM and 300µL MTT (Sigma-Aldrich Inc, Saint Louis, MO) were 
added to each well. The cells were incubated at 37∘C with 5% CO2 for 3.5 hours. The 
αMEM/MTT mixture was aspirated and 500uL dimethyl sulfoxide (AmericanBio Inc, 
Natick, MA) was added to each well. Well absorbance was read at 570nm using a BioTek 
Synergy 2 Multi-mode Microplate Reader (BioTek Instruments Inc, Winooski, VT). 
 
Oxygen Consumption Rate Quantification 
 At each timepoint (7 and 21 days post-confluence), oxygen consumption rate 
and mitochondrial function were assessed using the Seahorse XF24 mitochondrial stress 
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test. Seahorse XF Assay Medium (Seahorse Bioscience Inc., North Billerica, MA) was 
supplemented with 20mM D-glucose (VWR International, Rador, PA), 4mM L-glutamine 
(Life Technologies, Beverly, MA), and 5mM sodium pyruvate (Life Technologies, Beverly, 
MA), and the pH was adjusted to 7.4 at 37∘C. The experimental media were aspirated 
from the wells and each well was washed with supplemented XF Assay Medium before 
being filled to a final volume of 450µL. After changing to the supplemented XF Assay 
Medium, the cells were incubated in a non-CO2 incubator at 37∘C for a minimum of 20 
minutes.  
The XF24 sensor cartridge (Seahorse Bioscience Inc., North Billerica, MA) was 
hydrated with XF Calibrant Solution (Seahorse Bioscience Inc., North Billerica, MA)  and 
incubated in a non-CO2 incubator at 37∘C for a minimum of four hours prior to the assay. 
Oxygen consumption was manipulated using three inhibitors of oxidative 
phosphorylation (see Figure 2): oligomycin (EMD Millipore, Billerica, MA), an inhibitor of 
the F0 subunit of ATP synthase ; carbonyl cyanide-p-(trifluoromethoxy)phenlhydrazone 
(FCCP) (Sigma-Aldrich Inc, Saint Louis, MO), an uncoupling agent; and antimycin A (Enzo 
Life Sciences Inc, Farmingdale, NY), an inhibitor of complex III in the electron transport 
chain. Oxidative phosphorylation inhibitors were dissolved in supplemented XF Assay 
Medium at the following concentrations: 3 μM oligomycin A; 2 μM FCCP; 3 μM  
antimycin A. Inhibitor concentrations were chosen based on titration in order to 
produce a response at all timepoints. The inhibitors were loaded into the sensor 
cartridge at a volume of 50uL. Basal OCR was measured four times for 1.5 minutes each 
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separated by a 5 minute mix and a 30 second wait. Following the basal measurement, 3 
μM oligomycin was injected into all wells in order to determine the oxygen consumption 
accounted for by proton leak. Proton leak OCR was measured for three cycles of 3.5 
minutes mix, 30 second wait, and 2 minutes measure. After the proton leak 
measurement, 2 μM FCCP was injected into all wells to assess the cells’ maximal 
respiration rate. Maximal respiration was measured for three cycles of 5.5 minutes mix, 
and 1.5 minutes measure. Finally, 3 μM antimycin A was injected into all wells to assess 
oxygen consumption accounted for by non-mitochondrial respiration. Non-
mitochondrial respiration was measured for three cycles of 4 minutes mix, 30 seconds 
wait, and 2.5 minutes measure (Figure 3).  
All wells were imaged before and after the stress test using an Olympus Stereo 
Fluorescence Microscope (Olympus Corporation of the Americas, Center Valley, PA), and 
any showing significant separation of the cell layer from the surface of the well or 
damage to the cell layer as a result of the stress test were excluded from the final OCR 
quantification. Measures of oxygen consumption were calculated according to the 
Seahorse Bioscience XF Stress Test Report Generator User Guide (Table 2) and all values 
were normalized to well DNA content.   
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Table 2. Oxygen consumption rate calculations. All OCR data were normalized to well DNA 
content prior to rate measurement calculation (Adapted from Seahorse Bioscience XF Stress 
Test Report Generator User Guide). 
Parameter Rate Measurement Calculation 
Non-Mitochondrial 
Respiration 
Minimum rate measurement after Antimycin A injection 
 
 
Basal Respiration (Final rate measurement before Oligomycin injection) - (Non-Mitochondrial 
Respiration) 
Maximal Respiration (Maximum rate measurement after FCCP injection) - (Non-Mitochondrial Respiration) 
H+ (Proton) Leak (Minimum rate measurement after Oligomycin injection) - (Non-Mitochondrial 
Respiration) 
 
ATP Production (Last rate measurement before Oligomycin injection) - (Minimum rate measurement 
after Oligomycin injection) 
 
Spare Respiratory 
Capacity 
(Maximal Respiration) - (Basal Respiration) 
 
 
 
DNA and Protein Extraction and Quantification 
 DNA and protein were extracted from each well using an extraction buffer 
consisting of 4M guanidine HCl (Sigma-Aldrich Inc, Saint Louis, MO) with 1% Triton X-100 
(Sigma-Aldrich Inc, Saint Louis, MO) in 1X TE (Life Technologies Inc, Beverly, MA). DNA 
and protein from each well were extracted in 250 μL of extraction buffer, transferred to 
1.5 mL microcentrifuge tubes, and vortexed thoroughly. After vortexing, the extracted 
DNA and protein were diluted with 250 μL DNAse-free water and vortexed again. The 
diluted DNA and protein were stored at -80∘C.  
 DNA content was quantified using a Quant-iTTM PicoGreen dsDNA Assay Kit (Life 
Technologies Inc, Beverly, MA) according to the manufacturer’s instructions. Excitation 
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was measured at a wavelength of 485 nm and a bandwidth of 20 nm, and emission was 
measured at a wavelength of 530 nm and a bandwidth of 25 nm using a BioTek Synergy 
2 Multi-mode Microplate Reader. A standard curve was generated and used to calculate 
the amount of DNA in each well based on the PicoGreen emission intensity.   Protein 
content was quantified using a MicroBCA protein assay kit (Thermo Fisher Scientific, 
Waltham, MA). Absorbance was read at 562 nm using a BioTek Synergy 2 Multi-mode 
Microplate Reader In order to keep the protein concentration within the detection limits 
of the MicroBCA reagent, all samples were diluted 1:20 in RNAse and DNAse free water 
prior to adding the reagent.  
 
Statistical Analysis 
 Outcome measures were compared among media conditions and time-points 
using two-way analyses of variance (ANOVA). Data transformation was performed when 
necessary. Post-hoc tests were performed following the ANOVA to identify differences 
due to the media condition and timepoint. Significance level of p<0.05 was used for all 
analyses. 
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RESULTS 
 
Pilot study outcomes 
Overall oxygen consumption increased with chondrocyte differentiation from 
day 7 to day 14, and from day 14 to day 21, but decreased slightly from day 21 to day 28 
(Figure 5A). Total DNA content did not change from day 7 to day 14, but decreased 
significantly from day 14 to day 21 (p<0.05), indicating that some portion of the 
differentiating cells underwent cell death during this period (Figure 5B). Comparison of 
various DNA-normalized OCR parameters between the day 7 and day 21 timepoints 
revealed that non-mitochondrial respiration, basal respiration, maximal respiration rate, 
ATP production, and spare capacity all increased significantly between these two 
timepoints (Figure 5C). Spare respiratory capacity increased from day 7 to day 14 
(p<0.05), none of the other OCR parameters differed between day 7 and day 21 
(p>0.15). None of the OCR parameters were different between day 21 and day 28 
(p>0.12). Due to the dramatic increase in oxidative respiration and apparent cell death 
between day 7 and day 21, these days were identified as the key timepoints at which 
further investigation should be focused. 
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Figure 5. Pilot study of OCR in differentiating ATDC5 chondroprogenitor cell culture. ATDC5 
chondroprogenitors were cultured in a differentiating medium supplemented with ascorbic acid, 
1X ITS, and 4 mM βGP. At 7, 14, 21, and 28 post-confluence, (A) OCR was assessed using a 
Seahorse XF24 Mitochondrial Stress Test, and (B) total DNA content was quantified using a 
PicoGreen fluorescence assay. (C) Differentiating ATDC5 chondroprogenitors demonstrated 
increased DNA-normalized OCR parameters. * indicates p<0.05. 
 
  
 26 
β-glycerol phosphate induces morphological changes in the ATDC5 cell line 
 Microscopic examination of ATDC5 chondroprogenitors cultured under 
differentiating media conditions revealed that only those supplemented with 4 mM β-
glycerol phosphate underwent morphological changes consistent with matrix 
mineralization. Between 7 and 14 days after the switch to differentiating media, 
opaque, grainy patches became visible in wells supplemented with 4 mM βGP. These 
wells continued to darken between 14 and 21 days, dramatically increasing in opacity 
(Figure 6). Additionally, during DNA and protein extraction, cells supplemented with 4 
mM βGP were noticeably more difficult to detach from the well surface. These wells 
often contained solid deposits which needed to be scraped off during the extraction. 
This apparent calcification in wells with 4 mM βGP was consistent across all 
concentrations of inorganic phosphate; Half Pi and Quarter Pi groups appeared to be no 
less susceptible to this effect than the Full Pi group.  Chondrocytes not supplemented 
with β-glycerol phosphate did not darken or produce calcified deposits regardless of the 
concentration of inorganic phosphate available, suggesting that their presence was 
solely dependent on the presence of organic phosphate. 
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Figure 6. Morphological changes in the presence of β-glycerol phosphate. ATDC5 chondrocytes 
develop hydroxyapatite mineral deposits when cultured in differentiating media containing βGP. 
Mineral deposits were visible upon microscopic examination between 7 and 14 days post-
confluence, and continued to increase from day 14 to day 21.  Chondrocytes cultured without 
βGP did not develop visible mineral deposits, regardless of the concentration of inorganic 
phosphate available. 
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β-glycerol phosphate induces mineralization in differentiated chondrocytes 
Alizarin red staining confirmed that the dark, grainy areas that developed in 
+βGP groups were in fact calcium-containing mineral deposits (Figure 7). Overall mineral 
accumulation increased significantly from day 7 to day 14 (p=0.0187) and from day 14 to 
day 21 (p<0.0001) but did not change from day 21 to day 28. Mineral accumulation was 
significantly higher under the Full Pi +βGP media condition than under the Full Pi –βGP 
condition (p<0.0001). Mineral accumulation was significantly higher under the Half Pi 
+βGP media condition than under the Half Pi –βGP condition (p<0.0001). There was no 
significant difference in the amount of mineral accumulated under the Full Pi +βGP and 
Half Pi +βGP media conditions (p>0.97) or under the Full Pi –βGP and Half Pi –βGP 
conditions (p>0.98). Further, there was some interaction between timepoint and media 
condition within the +βGP groups; mineralization increased significantly between day 14 
and day 21 for both the Full Pi +βGP and Half Pi +βGP groups (p<0.0001), coinciding with 
the morphological changes observed over the course of the experiment (Figure 6). 
There was no interaction between timepoint and media condition for the –βGP groups. 
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Figure 7. Mean mineral accumulation for each media condition. Calcified mineral accumulation 
was assessed using Alizarin red staining, and all values were normalized to cell number as 
approximated by MTT assay. Between day 14 and day 21, calcified mineral deposits appeared in 
wells supplemented with 4 mM β-glycerol phosphate (βGP), but did not appear in those without 
β-glycerol phosphate. Mineral deposits continued to accumulate between day 21 and day 28 in 
the wells supplemented with βGP, but did not appear in the wells without βGP. * indicates 
p<0.0001. 
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βGP-induced mineralization is associated with decreased protein accumulation  
Chondrocytes grown in differentiating media supplemented with 4 mM β-
glycerol phosphate accumulated less protein than those grown in media without β-
glycerol phosphate (Figure 8). While all groups cultured under differentiating media 
conditions demonstrated significant increases in protein content between day 7 and day 
21 (p<0.0262), this effect was far more pronounced in the –βGP groups. Mean protein 
content nearly tripled between day 7 and day 21 in the –βGP groups (p<0.0001) and the 
mean protein content of the –βGP groups at day 21 was twice that of the +βGP groups 
(p<0.0001). The effect of organic phosphate availability on protein accumulation was 
the opposite of its effect on mineral accumulation. Interestingly, while none of the +βGP 
groups accumulated more protein than the control group, the Quarter Pi +βGP group 
accumulated significantly more protein than either the Full Pi +βGP or Half Pi +βGP 
groups (p<0.0280). Similarly, the Quarter Pi –βGP group accumulated more protein than 
the Full Pi –βGP and Half Pi –βGP groups (p<0.0107). Despite the extreme phosphate 
restriction imposed on the Quarter Pi groups, their total protein accumulation was 
higher than the groups with greater total phosphate availability. 
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Figure 8. Mean protein concentration for each media condition. Protein concentration was 
assessed using MicroBCA Protein Assay Kit. Differentiation was associated with an increase in 
protein content at day 21 relative to day 7; all groups cultured in differentiating media 
demonstrated an increase in total protein content from day 7 to day 21. Supplementation with 4 
mM βGP appeared to reduce protein accumulation at day 21. Total protein accumulation 
appeared to have an inverse relationship with total (inorganic and organic) medium phosphate 
content. All values were normalized to well DNA content. * indicates p<0.05. 
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Oxygen consumption is affected by phosphate availability 
 Rates of basal respiration, ATP production, proton leakage, maximal respiration, 
spare capacity, and non-mitochondrial respiration were assessed at each timepoint 
using the Seahorse XF24 mitochondrial stress test.  
I. Basal respiration rate 
Basal respiration changed significantly over the course of the experiment, and 
was affected by both differentiation and phosphate availability (Figure 9). Basal OCR 
increased from day 7 to day 21 (p<0.0001). With the exception of the Quarter Pi +βGP 
group, all groups grown in differentiating media had higher basal OCRs than the control 
(p<0.0241). Basal respiration also differed within the differentiating media; basal 
respiration rate was significantly higher under the non-mineralizing conditions (-βGP) 
than under the mineralizing conditions (+βGP) (p<0.0011). While basal respiration rate 
increased from day 7 to day 21 for all differentiated groups, this change was particularly 
pronounced among the non-mineralizing groups; all of the non-mineralizing groups had 
far higher basal oxygen consumption at day 21 than at day 7 (p<0.0001).  
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Figure 9. Basal Respiration Rate. Basal respiration rate was elevated in ATDC5 
chondroprogenitors cultured in differentiating media. Cells cultured in media supplemented 
with 4 mM βGP (+βGP) had lower rates of basal respiration than did cells cultured without 4 mM 
βGP (-βGP). Basal respiration rate increased between day 7 and day 21. This effect was 
particularly pronounced in the three - βGP groups. All values are normalized to well DNA 
content. * indicates p<0.05. 
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II. ATP production 
ATP production changed in a pattern similar to that of basal respiration (Figure 
10). Chondrocytic differentiation resulted in an overall increase in ATP production 
relative to the undifferentiated control group for all groups except Quarter Pi –βGP 
(p=0.0001).  There was no difference in ATP production between the Quarter Pi –BGP 
group and the control(p=0.3811). As was the case with basal OCR, ATP production was 
significantly higher among non-mineralizing groups; -βGP groups had higher rates of ATP 
production than +βGP groups (p<0.0387) with the exception of the Full Pi +βGP, which 
was not significantly different from Full Pi –βGP (p=0.0587). Finally, the interaction 
between organic phosphate availability and ATP production mirrored that of basal OCR; 
while all of the differentiated groups increased ATP production from day 7 to day 21, 
the increase was far more pronounced among non-mineralizing (-βGP)  groups 
(p<0.001).  
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Figure 10. ATP Production. ATP production via oxidative phosphorylation was elevated in ATDC5 
chondroprogenitors cultured in differentiating media. Cells cultured in media supplemented 
with 4 mM βGP (+βGP) had lower rates of ATP production than did cells cultured without 4 mM 
βGP (-βGP). Oxygen consumption related to ATP production increased between day 7 and day 
21. This effect was particularly pronounced in the three - βGP groups. All values are normalized 
to well DNA content.* indicates p≤0.0001 
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III. Maximal respiration rate   
Maximal respiration rate was affected by both timepoint and media condition, 
but was less consistent than the changes observed in basal OCR and ATP production 
(Figure 11). While differentiation was associated with an overall increase in maximal 
OCR relative to the undifferentiated control, mineralizing (+βGP) differentiated 
chondrocytes did not have significantly higher maximal OCRs than the control 
(p>0.1148). Non-mineralizing (-βGP) groups demonstrated significantly higher OCRs 
than either the +βGP groups or the undifferentiated control group (p<0.0032). Inorganic 
phosphate availability did not affect maximal OCR among differentiated chondrocytes at 
either timepoint (p>0.087). Additionally, while maximal OCR increased overall from day 
7 to day 21 (p<0.0001), this increase is accounted for almost entirely by the –βGP 
differentiating groups. Maximal respiration rate doubled among non-mineralizing (-βGP) 
groups between day 7 and day 21 (p<0.0001), indicating a tremendous increase in 
oxidative capacity in cells that differentiated but were not able to mineralize the ECM. 
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Figure 11. Maximal Respiration Rate. Maximal oxygen consumption rate (Max OCR) was 
elevated in ATDC5 chondroprogenitors cultured in non-mineralizing differentiating media 
without 4 mM (-βGP).  Overall Max OCR increased from day 7 to day 21, but his effect largely 
accounted for by the massive increase in Max OCR among the –βGP groups. All values are 
normalized to well DNA content. * indicates p<0.005. 
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IV. Spare respiratory capacity  
Spare respiratory capacity was also affected by both timepoint and media 
condition in an almost identical pattern to their effects on maximal respiration (Figure 
12). While differentiation was associated with an overall increase in spare capacity 
relative to the undifferentiated control, mineralizing (+βGP) differentiated chondrocytes 
did not have significantly higher spare capacity than the control (p>0.3941). Non-
mineralizing (-βGP) groups demonstrated significantly greater spare capacity than either 
the +βGP groups or the undifferentiated control group (p<0.0262). Inorganic phosphate 
availability did not appear to affect spare capacity among differentiated chondrocytes at 
either timepoint (p>0.0894). As was the case with maximal OCR, while spare capacity 
increased overall from day 7 to day 21 (p<0.0001), this increase is accounted for almost 
entirely by the –βGP differentiating groups. Spare capacity doubled among non-
mineralizing (-βGP) groups between day 7 and day 21 (p<0.0001). 
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Figure 12. Spare Respiratory Capacity. Spare respiratory capacity increased in ATDC5 
chondroprogenitors cultured in non-mineralizing differentiating media without 4 mM (-βGP).  
Overall spare capacity increased from day 7 to day 21, but this effect was almost entirely 
accounted for by the large increase in spare capacity among the –βGP groups. All values are 
normalized to well DNA content. * indicates p<0.0262. 
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V. Non-mitochondrial respiration rate 
Non-mitochondrial respiration increased over time and was both affected by 
both differentiation and media condition (Figure 13). Overall non-mitochondrial 
respiration increased from day 7 to day 21 (p<0.0001). While non-mitochondrial 
respiration rate was higher under all differentiating media conditions compared to the 
control, this difference was most pronounced in the non-mineralizing (–βGP) groups; 
non-mitochondrial respiration doubled in –βGP groups between day 7 and day 21 
(p<0.0002). All differentiated cells cultured in non-mineralizing media had higher rates 
of non-mitochondrial respiration than the undifferentiated control (p<0.041). Among 
the +βGP experimental groups, only cells cultured in Quarter Pi medium had a 
significantly higher rate of non-mitochondrial respiration than the control (p=0.0037). 
While βGP-induced mineralization was associated with a lower rate of non-
mitochondrial respriation, it appears that decreased inorganic phosphate availability 
may also result in higher rates of non-mitochondrial respiration. 
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Figure 13. Non-Mitochondrial Respiration. Non-mitochondrial respiration rate (NMR) increased 
in ATDC5 chondroprogenitors cultured in non-mineralizing differentiating media without 4 mM 
(-βGP), and in cells cultured in Quarter Pi with 4 mM βGP (Quarter Pi +βGP). NMR increased 
between day 7 and day 21 in all differentiating cultures, but this effect was particularly 
pronounced under the –βGP media conditons. All values are normalized to well DNA content.  
* indicates p<0.05  
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DISCUSSION 
 
β-glycerol phosphate induces extracellular matrix mineralization 
In attempting to define the role of phosphate in chondrocyte differentiation and 
mineralization, one of the primary goals of this study was to determine whether the 
source of phosphate provided to differentiating chondrocytes affected the cells’ ability 
to terminally differentiate and mineralize the extracellular matrix. This was achieved by 
culturing undifferentiated ATDC5 chondroprogenitors with 0.25-1.0 mM inorganic 
phosphate and in the presence and absence of 4 mM β-glycerol phosphate. Our study 
found that matrix mineralization could be induced in ATDC5 chondroprogenitor cells 
cultured under differentiating conditions by supplementing the medium with 4 mM β-
glycerol phosphate. While our assay of mineral production did not include the Quarter 
Pi experimental group, the same morphological changes were observed in all 
mineralizing (+βGP) groups, regardless of the concentration of inorganic phosphate in 
the culture medium. While some studies have shown that differentiated ATDC5 
chondrocytes will mineralize the ECM given a high enough concentration of inorganic 
phosphate (Magne, et al. 2003; Fujita, et al. 2000), our results show that even under 
conditions of extreme inorganic phosphate restriction, 4 mM βGP was sufficient to 
induce mineralization. Additionally, mineral accumulation was independent of inorganic 
phosphate concentration; Alizarin red staining revealed that the Full Pi +βGP group 
accumulated the same amount of mineral as Half Pi +βGP group. While the Quarter Pi 
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media condition was not included in the mineral accumulation experiment, the same 
morphological changes were observed in the all groups cultured with βGP. Together, 
these results suggest that organic phosphate in the form of β-glycerol phosphate is 
preferentially metabolized by differentiated chondrocytes to facilitate extracellular 
matrix mineralization. 
These results were consistent with in vivo findings that progressive stages of 
chondrocyte differentiation in the growth plate coincide with a progressive increase in 
extracellular phosphate concentration (Denison, et al. 2009; Melrose, et al. 2016). 
Chondrocytes in the growth plate separate the phosphate ion from βGP in a reaction 
catalyzed by the cell-surface enzyme, alkaline phosphatase, before taking up the ion 
through a sodium-dependent phosphate transporter (Penido and Alon, 2012). Obtaining 
free phosphate from βGP requires the enzymatic cleavage of the phosphate group 
before it can be taken up by the cell and incorporated into matrix vesicles, but free 
inorganic phosphate can be transported into the cell without requiring further 
processing. While free inorganic phosphate may seem to be the ideal source of 
phosphate as it does not require enzymatic cleavage, our results suggest that organic 
phosphate induces chondrocyte mineralization at lower concentrations when compared 
to inorganic phosphate. It is possible that the organic component of βGP allows the 
molecule to act as an extracellular signal to promote phosphate uptake and matrix 
mineralization. Further investigation is necessary to better understand the process of 
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phosphate uptake by chondrocytes, and to fully characterize the differences between 
organic and inorganic sources of phosphate. 
 
Protein accumulation is reduced in mineralizing conditions and increased under severe 
Pi restriction 
Differentiating chondrocytes accumulated protein between day 7 and day 21, a 
pattern consistent with the synthesis of the collagen and proteoglycan-rich extracellular 
matrix. Cells cultured in the presence of βGP produced significantly less protein, 
suggesting that chondrocyte mineralization is associated with a reduction in protein 
synthesis. This pattern is consistent with the current understanding of chondrocyte 
differentiation during endochondral ossification; as chondrocytes in the late 
hypertrophic zone enter the terminal stages of differentiation, they cease collagen 
production and undergo apoptosis, and release mineralizing matrix vesicles in the 
process (Kozhemyakina, et al. 2015; Melrose, et al. 2016). Since the cells cultured 
without βGP were unable to mineralize the extracellular matrix, they did not undergo 
terminal differentiation and continued to accumulate large amounts of extracellular 
matrix proteins. These findings are consistent with previous work in mineralizing ATDC5 
cells. A study by Cooke and Gerstenfeld (2015) found that mineralizing ATDC5 
chondroprogenitors cultured in the presence of βGP exhibited a downregulation in 
genes encoding extracellular matrix components, specifically collagen X and aggrecan, at 
day 35 post-confluence, while cells cultured without βGP continued to express high 
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levels of these extracellular matrix components. Similar effects have been observed in 
vivo in studies of both endochondral ossification and fracture healing.  Endochondral 
ossification was disturbed in mice in which the sodium-dependent Pi transporter was 
inactivated, preventing the uptake of phosphate by differentiating chondrocytes. 
Hypertrophic chondrocytes in these mice failed to mineralize the ECM or undergo 
apoptosis, instead continuing to synthesize proteoglycans and produce a disorganized 
growth plate (Sugita, et al. 2010). In a study of fracture callus composition, mice given a 
phosphate restricted diet exhibited delayed callus mineralization and produced calluses 
with significantly  greater volume of cartilage (Hussein, et al. 2014). 
Interestingly, cells cultured under the Quarter Pi +βGP media condition 
accumulated significantly more protein than the Half Pi +βGP or Full Pi +βGP groups. 
Similarly, the Quarter Pi –βGP accumulated more protein than the Half Pi –βGP or Full Pi 
–βGP groups. Together, this suggests that while protein accumulation is primarily 
determined by the ability of cells to mineralize, it is also related to inorganic phosphate 
availability. Chondrocytes can uptake phosphate through the sodium-dependent Pi 
transporter from both organic and inorganic sources, and it has been shown that 
alkaline phosphatase activity is downregulated in differentiating chondrocytes by 
increased culture Pi concentration (Kimata, et al. 2010). It is likely that under conditions 
of severe inorganic phosphate restriction, it is more difficult for chondrocytes to achieve 
the intracellular Pi concentration required for terminal differentiation, and that their 
time in the collagen and proteoglycan synthesizing stages of differentiation is extended. 
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Quantification of the specific collagen and proteoglycan products accumulated under 
different media conditions would contribute to a better understanding of which cellular 
products contribute to the increased protein synthesis observed in the absence of βGP. 
 
Chondrocyte differentiation results in increased oxidative respiration 
Chondrocyte differentiation was associated with an overall increase in oxidative 
metabolism. This trend is consistent with recent studies of pre-osteoblast and 
mesenchymal stem cell lines, in which osteoblastic differentiation was associated with 
an overall increase in oxidative phosphorylation, and the cell’s primary source of energy 
production switched from glycolysis to oxidative phosphorylation (Rosen, et al. 2014; 
Shum, et al. 2016). While we did not analyze the change in glycolysis rate during 
differentiation, nearly all measures of oxidative phosphorylation increased in 
differentiated chondrocytes compared to the undifferentiated control. The observed 
increase in oxidative phosphorylation supports the hypothesis that chondrogenic 
differentiation is an energy-intensive process. The need to address increased energy 
demands in differentiating chondrocytes reflects the highly active process of 
differentiation and extracellular matrix synthesis; proliferative chondrocytes are 
engaged in rapid, energy-intensive cell division, and hypertrophic chondrocytes rapidly 
secrete and remodel the ECM.  At the same time, the dramatically increased rate of 
oxygen-intensive energy production is more difficult to explain in vivo; the environment 
in which chondrocyte differentiation takes place – the cartilaginous, largely avascular 
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growth plate – is particularly oxygen-poor (Shapiro and Srivinas, 2006).  A recent study 
by Bentovim, et al. (2012) found that in vivo extracellular matrix secretion was 
dependent on the expression of HIF-1, which allowed growth plate chondrocytes to 
survive the combination of hypoxia and energy-intensive ECM secretion by reducing 
cellular oxygen consumption through the inhibition of the mitochondrial tricarboxylic 
acid (TCA) cycle. However, our results indicate that oxygen consumption and oxidative 
phosphorylation increased dramatically during chondrocyte differentiation. It is difficult 
to determine whether the difference in oxygen availability between the growth plate 
microenvironment and that of the cell culture contributed to the increase in oxidative 
phosphorylation in our study. A recent study has shown that harvested bovine primary 
articular chondrocytes cultured in a monolayer dramatically increase their rate of 
oxidative phosphorylation unless they are cultured under hypoxic conditions (Heywood 
and Lee, 2016).  While there are significant differences between a mature primary 
chondrocyte and an undifferentiated chondrocyte cell line, it is possible that repeating 
the experiment under hypoxic conditions closer to the microenvironment of the growth 
plate would attenuate the increase in oxidative phosphorylation observed in 
differentiating chondrocytes. However, we observed no increase in oxidative respiration 
in our undifferentiated control group, suggesting that the increased OCRs observed in 
the differentiating groups were related to differentiation rather than oxygen availability. 
In a recent study of osteoblast differentiation in mesenchymal stem cells, Shum et al. 
(2016) observed an increase in oxidative phosphorylation that coincided with 
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downregulation in HIF-1. As chondrocytes are mesenchymal in origin, it is possible that 
this mechanism is shared between stem cells undergoing osteoblast and chondrocyte 
differentiation. Downregulation of HIF-1 in differentiating stem cells provides a possible 
mechanism with which our results might be explained, and one which invites further 
investigation. 
 
ECM mineralization is associated with decreased oxidative respiration and protein 
accumulation 
Across all parameters of oxidative phosphorylation, extracellular matrix 
mineralization was associated with a lower rate of oxygen consumption relative to the 
non-mineralizing groups. The differences in oxidative phosphorylation between 
differentiating ATDC5 chondroprogenitors cultured in mineralizing (+βGP) media and 
those cultured in non-mineralizing (-βGP) media were striking. Although both groups 
underwent differentiation and increased their total oxygen consumption between day 7 
and day 21, groups cultured in non-mineralizing media far exceeded the mineralizing 
groups in this regard. 
Basal respiration rate, ATP production, maximal respiration rate, and spare 
respiratory capacity were all significantly higher in cells cultured without βGP, which did 
not mineralize the extracellular matrix, than in cells that were able to mineralize. During 
endochondral ossification, hypertrophic chondrocytes withdraw from the cell cycle but 
remain highly active, remodeling the surrounding extracellular matrix and secreting type 
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X collagen, proteoglycans, and metalloproteinases to prepare the matrix for 
mineralization (Kozhemyakina, et al. 2015; Melrose, et al. 2016). Mineralization, by 
comparison, is a relatively low-energy process. Hypertrophic chondrocytes that have 
achieved a sufficient intracellular phosphate concentration undergo apoptosis, releasing 
mineral-containing matrix vesicles and apoptotic bodies into the extracellular matrix 
(Karsenty, et al. 2003; Mebarek, et al. 2013). Our results showed that preventing 
extracellular matrix mineralization by withholding βGP resulted in relatively higher rates 
of oxidative phosphorylation. This suggests that differentiated chondrocytes that do not 
receive sufficient organic phosphate continue the energy-intensive metabolic process of 
synthesizing and remodeling the extracellular matrix. This hypothesis is supported by 
the tremendous increase in total protein content among –βGP groups between day 7 
and day 21. Total protein content increased significantly for all differentiating groups 
between day 7 and day 21, but was inhibited by mineralization. Under the +βGP 
condition, total protein content increased by 40-90% from day 7 to day 21. This protein 
accumulation was modest in comparison to that of the –βGP groups, whose total 
protein content increased by approximately 120-300% between day 7 and day 21. This 
discrepancy in protein synthesis largely explains the difference in OCR between +βGP 
and –βGP media conditions; without βGP to induce terminal differentiation, apoptosis, 
and matrix mineralization, cells cultured under the –βGP conditions continued the 
energy-intensive process of extracellular matrix synthesis and remodeling. 
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Limitations and Future Work 
 While 4 mM βGP was sufficient to induce mineralization regardless of inorganic 
phosphate availability, we cannot assert that the increase in mineral accumulation was 
solely due to the nature of the phosphate source rather than the total amount of 
phosphate in the culture medium. Future studies could control for this variable by 
including additional experimental groups supplemented with 4 mM inorganic phosphate 
in addition to groups supplemented with 4 mM βGP. Additional titrations of inorganic 
phosphate at higher concentrations in the culture media would also help to determine 
whether a preference for organic phosphate is universal or if the preference is limited to 
conditions of low inorganic phosphate availability. 
 Additionally, this experiment focused on the changes in oxidative metabolism 
that take place during differentiation and mineralization, but did not examine the 
changes in glycolytic activity during these processes. In order to more fully characterize 
the metabolic changes that occur during chondrocyte differentiation and mineralization, 
future studies might investigate the extracellular acidification rate (ECAR) and 
OCR/ECAR ratio. ECAR serves as an indicator of the rate at which cells are producing 
acidic glycolytic end products, while the OCR/ECAR ratio can characterize changes in 
cellular preference for each metabolic pathway. Determining the relationship between 
ECAR, OCR/ECAR, and the processes of differentiation and mineralization would help to 
provide a more complete model of chondrocyte metabolism. 
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 While this study assessed chondrogenesis and osteogenesis by measuring 
protein and mineral accumulation, genetic analysis would improve the precision of our 
conclusions and help to identify the mechanisms by which phosphate availability, 
cellular respiration, and differentiation are related. Future investigation should include 
the assessment of mRNA expression for selective genes – such as HIF-1, Osx, ColXa1, 
and Col2a1 – that are representative of cellular oxidative phenotype and the 
proliferative and hypertrophic stages of chondrocyte differentiation. 
 Finally, these experiments were limited by the inherent differences between the 
environment in a cell culture and in the growth plate during endochondral ossification. 
Much of the chondrocyte differentiation that takes place during endochondral 
ossification is directly related to the chondrocyte’s position in the growth plate and the 
phosphate gradient established along the growth plate. In the highly-organized growth 
plate, cells at a given stage of differentiation are stratified into different zones. This level 
of organization is not possible in the cell culture model, and chondrocytes at various 
stages of differentiation may contribute to OCR measurement at any given timepoint. 
Additionally, since the cells were not cultured in a hypoxic environment like that of the 
growth plate, some of mechanisms that normally inhibit chondrocyte oxidative 
phosphorylation in vivo may not have been active in our cell model. 
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Conclusion 
In this study, we attempted to define the relationship between chondrocyte 
differentiation and oxidative respiration, and to assess the role of organic and inorganic 
sources of phosphate in chondrocyte development and mineralization. Our finding that 
chondrocyte differentiation is associated with increased oxygen consumption adds to 
the current understanding of stem cell metabolism. The identification of organic 
phosphate as a key regulator of chondrocyte mineralization furthers our understanding 
of fracture healing and endochondral ossification, and has helped to establish a 
relationship between extracellular matrix mineralization and oxidative phosphorylation. 
Together, these findings have identified new targets for further investigation into the 
mechanisms that underlie these key developmental processes. Characterizing the 
process of chondrogenic differentiation and matrix mineralization is essential to 
improving the treatment of fractures and disorders of bone development. An estimated 
100,000 fractures undergo nonunion each year in the United States, a complication 
which results in both significant hardship for patients and increased costs for patients 
and healthcare providers (Hak, et al. 2014). By characterizing the key mechanisms that 
direct chondrocyte-mediated bone formation, researchers can identify risk factors for 
impaired fracture healing and targets for new therapies. 
Studying the underlying mechanisms of cartilage formation and mineralization 
contributes not only to the field of orthopaedic research, but to furthering our 
understanding of a variety of pathological conditions in which mineralization goes awry. 
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Osteoarthritis involves the pathological mineralization of articular cartilage, resulting in 
pain and loss of mobility (reviewed in Anderson, et al. 2010). Obesity and diabetes, 
diseases known to affect cellular metabolic function, are associated with delayed or 
incomplete fracture healing and reduced bone quality. Both diseases have been linked 
to changes in phosphate metabolism and serum phosphate concentration (Anderson, et 
al. 2010; Brown, et al. 2014; Burrus, et al. 2016). Vascular calcification – the abnormal 
mineralization of blood vessel walls – is a key risk factor for cardiovascular mortality, 
and is caused by the pathological differentiation of vascular smooth muscle cells into an 
osteochondrogenic lineage (reviewed in Leem and Lee, 2016). High serum phosphate 
has been identified as a risk factor for vascular calcification, suggesting that phosphate 
may promote pathological calcification through the same pathways by which it induces 
chondrocyte differentiation and mineralization (Figueiredo, et al. 2013). Studying the 
processes by which stem cells differentiate into chondrocytes, which in turn lay the 
foundation for bone, may allow researchers to find common mechanisms by which 
these apparently dissimilar pathologies arise. 
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